nach oben

Clinical Reviews in Allergy & Immunology

Erschienen in:

01.02.2015

Infection in Severe Asthma Exacerbations and Critical Asthma Syndrome

verfasst von: Christian E. Sandrock, Andrew Norris

Erschienen in: Clinical Reviews in Allergy & Immunology | Ausgabe 1/2015

Einloggen, um Zugang zu erhalten

Abstract

In chronic persistent asthma and severe acute exacerbations of bronchial asthma, infectious agents are the predominant triggers that drive disease and airway pathobiology. In acute exacerbations of bronchial asthma (AEBA) including near fatal and fatal asthma, viral agents, particularly human rhinovirus-C, respiratory syncytial virus and influenza A appear to be the more prevalent and recurring threats. Both viral, and to a lesser extent bacterial agents, can play a role, and co-infection may also be present and worsen prognosis in hospitalized patients, placing a portion at risk for critical asthma syndrome. During severe acute exacerbations, infectious agents must be treated empirically, but the initial treatment regimens can vary and viral coverage may also vary based on seasonality and patient age. Early treatment with ceftriaxone and azithromycin, along with oseltamivir in winter months, should be initiated with all cases of severe exacerbations where infection is suspected, and definitely in critical asthma syndrome until infection is excluded by appropriate diagnostic testing. In this manuscript we will outline the impact of the major viral agents on severe asthma including the data from the 2009 H1N1 influenza pandemic. The role of bacterial infections in acute exacerbations of asthma will also be reviewed as well as the benefit of empiric antibiotics and the role of macrolides in both acute and chronic asthma.

Monto AS, Sullivan KM (1993) Acute respiratory illness in the community. Frequency of illness and the agents involved. Epidemiol Infect 110(1):145–160PubMedCentralPubMedCrossRef

Johnston SL et al (1995) Community study of role of viral infections in exacerbations of asthma in 9–11 year old children. BMJ 310(6989):1225–1229PubMedCentralPubMedCrossRef

Johnston SL et al (1996) The relationship between upper respiratory infections and hospital admissions for asthma: a time-trend analysis. Am J Respir Crit Care Med 154(3 Pt 1):654–660PubMedCrossRef

MacDowell AL, Bacharier LB (2005) Infectious triggers of asthma. Immunol Allergy Clin North Am 25(1):45–66PubMedCrossRef

Carlsen KH et al (1984) Respiratory virus infections and aeroallergens in acute bronchial asthma. Arch Dis Child 59(4):310–315PubMedCentralPubMedCrossRef

Dales RE et al (1996) Respiratory infections and the autumn increase in asthma morbidity. Eur Respir J 9(1):72–77PubMedCrossRef

Tan WC et al (2003) Epidemiology of respiratory viruses in patients hospitalized with near-fatal asthma, acute exacerbations of asthma, or chronic obstructive pulmonary disease. Am J Med 115(4):272–277PubMedCrossRef

Corne JM et al (2002) Frequency, severity, and duration of rhinovirus infections in asthmatic and non-asthmatic individuals: a longitudinal cohort study. Lancet 359(9309):831–834PubMedCrossRef

Wark PA et al (2005) Asthmatic bronchial epithelial cells have a deficient innate immune response to infection with rhinovirus. J Exp Med 201(6):937–947PubMedCentralPubMedCrossRef

10.

Yamaya M (2012) Virus infection-induced bronchial asthma exacerbation. Pulm Med 2012:834826PubMedCentralPubMedCrossRef

11.

Calhoun WJ et al (1991) Experimental rhinovirus 16 infection potentiates histamine release after antigen bronchoprovocation in allergic subjects. Am Rev Respir Dis 144(6):1267–1273PubMedCrossRef

12.

de Gouw HW et al (1998) Relationship between exhaled nitric oxide and airway hyperresponsiveness following experimental rhinovirus infection in asthmatic subjects. Eur Respir J 11(1):126–132PubMedCrossRef

13.

Sanders SP et al (2004) Role of nasal nitric oxide in the resolution of experimental rhinovirus infection. J Allergy Clin Immunol 113(4):697–702PubMedCrossRef

14.

Marshall JS, King CA, McCurdy JD (2003) Mast cell cytokine and chemokine responses to bacterial and viral infection. Curr Pharm Des 9(1):11–24PubMedCrossRef

15.

Jolly S, Detilleux J, Desmecht D (2004) Extensive mast cell degranulation in bovine respiratory syncytial virus-associated paroxystic respiratory distress syndrome. Vet Immunol Immunopathol 97(3–4):125–136PubMedCrossRef

16.

Hu Y et al (2012) Mast cell-induced lung injury in mice infected with H5N1 influenza virus. J Virol 86(6):3347–3356PubMedCentralPubMedCrossRef

17.

Wang S et al (2010) Influenza virus-cytokine-protease cycle in the pathogenesis of vascular hyperpermeability in severe influenza. J Infect Dis 202(7):991–1001PubMedCrossRef

18.

Guilbert TW, Denlinger LC (2010) Role of infection in the development and exacerbation of asthma. Expert Rev Respir Med 4(1):71–83PubMedCentralPubMedCrossRef

19.

Hakonarson H et al (1998) Mechanism of rhinovirus-induced changes in airway smooth muscle responsiveness. J Clin Invest 102(9):1732–1741PubMedCentralPubMedCrossRef

20.

Makela MJ et al (1998) Viruses and bacteria in the etiology of the common cold. J Clin Microbiol 36(2):539–542PubMedCentralPubMed

21.

Atmar RL et al (1998) Respiratory tract viral infections in inner-city asthmatic adults. Arch Intern Med 158(22):2453–2459PubMedCrossRef

22.

Gern JE (2010) The ABCs of rhinoviruses, wheezing, and asthma. J Virol 84(15):7418–7426PubMedCentralPubMedCrossRef

23.

Lee WM et al (2012) Human rhinovirus species and season of infection determine illness severity. Am J Respir Crit Care Med 186(9):886–891PubMedCentralPubMedCrossRef

24.

Bizzintino J et al (2011) Association between human rhinovirus C and severity of acute asthma in children. Eur Respir J 37(5):1037–1042PubMedCentralPubMedCrossRef

25.

Cox DW et al (2013) HRV-C infection in young children with acute wheeze is associated with increased acute respiratory hospital admissions. Am J Respir Crit Care Med 188:1358–64PubMedCrossRef

26.

Grunberg K et al (2001) Rhinovirus-induced airway inflammation in asthma: effect of treatment with inhaled corticosteroids before and during experimental infection. Am J Respir Crit Care Med 164(10 Pt 1):1816–1822PubMedCrossRef

27.

Rakes GP et al (1999) Rhinovirus and respiratory syncytial virus in wheezing children requiring emergency care. IgE and eosinophil analyses. Am J Respir Crit Care Med 159(3):785–790PubMedCrossRef

28.

Teichtahl H, Buckmaster N, Pertnikovs E (1997) The incidence of respiratory tract infection in adults requiring hospitalization for asthma. Chest 112(3):591–596PubMedCrossRef

29.

Simpson JL et al (2003) Use of induced sputum for the diagnosis of influenza and infections in asthma: a comparison of diagnostic techniques. J Clin Virol 26(3):339–346PubMedCrossRef

30.

Falsey AR et al (2005) Respiratory syncytial virus infection in elderly and high-risk adults. N Engl J Med 352(17):1749–1759PubMedCrossRef

31.

Hayashi S, Hogg JC (2007) Adenovirus infections and lung disease. Curr Opin Pharmacol 7(3):237–243PubMedCrossRef

32.

Marin J et al (2000) Persistence of viruses in upper respiratory tract of children with asthma. J Infect 41(1):69–72PubMedCrossRef

33.

Macek V et al (1994) Persistent adenoviral infection and chronic airway obstruction in children. Am J Respir Crit Care Med 150(1):7–10PubMedCrossRef

34.

Papadopoulos NG et al (2011) Viruses and bacteria in acute asthma exacerbations—a GA(2) LEN-DARE systematic review. Allergy 66(4):458–468PubMedCrossRef

35.

Williams JV et al (2005) Human metapneumovirus infection plays an etiologic role in acute asthma exacerbations requiring hospitalization in adults. J Infect Dis 192(7):1149–1153PubMedCentralPubMedCrossRef

36.

Khetsuriani N et al (2007) Prevalence of viral respiratory tract infections in children with asthma. J Allergy Clin Immunol 119(2):314–321PubMedCrossRef

37.

Dao CN et al (2010) Adult hospitalizations for laboratory-positive influenza during the 2005–2006 through 2007–2008 seasons in the United States. J Infect Dis 202(6):881–888PubMedCrossRef

38.

Kloepfer KM et al (2012) Increased H1N1 infection rate in children with asthma. Am J Respir Crit Care Med 185(12):1275–1279PubMedCentralPubMedCrossRef

39.

Skarbinski J et al (2011) Hospitalized patients with 2009 pandemic influenza A (H1N1) virus infection in the United States—September-October 2009. Clin Infect Dis 52(Suppl 1):S50–S59PubMedCrossRef

40.

Van Kerkhove MD et al (2011) Risk factors for severe outcomes following 2009 influenza A (H1N1) infection: a global pooled analysis. PLoS Med 8(7):e1001053PubMedCentralPubMedCrossRef

41.

Mortensen E. et al (2013) Epidemiology and outcomes of adults with asthma who were hospitalized or died with 2009 pandemic influenza A (H1N1)—California, 2009. Influenza Other Respi Viruses

42.

Jain S et al (2009) Hospitalized patients with 2009 H1N1 influenza in the United States, April-June 2009. N Engl J Med 361(20):1935–1944PubMedCrossRef

43.

Lu PJ et al (2011) A Influenza (H1N1) 2009 monovalent vaccination among adults with asthma, U.S., 2010. Am J Prev Med 41(6):619–626PubMedCrossRef

44.

Cazzola M, Matera MG, Rossi F (1991) Bronchial hyperresponsiveness and bacterial respiratory infections. Clin Ther 13(1):157–171PubMed

45.

El Sayed Zaki M, Raafat D, El Metaal AA (2009) Relevance of serology for Mycoplasma pneumoniae diagnosis compared with PCR and culture in acute exacerbation of bronchial asthma. Am J Clin Pathol 131(1):74–80PubMedCrossRef

46.

Nagayama Y et al (2007) Bacterial colonization in respiratory secretions from acute and recurrent wheezing infants and children. Pediatr Allergy Immunol 18(2):110–117PubMedCrossRef

47.

Zhang Q et al (2012) Bacteria in sputum of stable severe asthma and increased airway wall thickness. Respir Res 13:35PubMedCentralPubMedCrossRef

48.

Talbot TR et al (2005) Asthma as a risk factor for invasive pneumococcal disease. N Engl J Med 352(20):2082–2090PubMedCrossRef

49.

Klemets P et al (2010) Risk of invasive pneumococcal infections among working age adults with asthma. Thorax 65(8):698–702PubMedCrossRef

50.

Essilfie AT et al (2012) Combined Haemophilus influenzae respiratory infection and allergic airways disease drives chronic infection and features of neutrophilic asthma. Thorax 67(7):588–599PubMedCrossRef

51.

Seddon PC et al (1992) Branhamella catarrhalis colonization in preschool asthmatics. Pediatr Pulmonol 13(3):133–135PubMedCrossRef

52.

Lehtinen P et al (2006) Bacterial coinfections in children with viral wheezing. Eur J Clin Microbiol Infect Dis 25(7):463–469PubMedCrossRef

53.

Lieberman D et al (2003) Atypical pathogen infection in adults with acute exacerbation of bronchial asthma. Am J Respir Crit Care Med 167(3):406–410PubMedCrossRef

54.

Cosentini R et al (2008) Severe asthma exacerbation: role of acute Chlamydophila pneumoniae and Mycoplasma pneumoniae infection. Respir Res 9:48PubMedCentralPubMedCrossRef

55.

Wark PA et al (2002) Chlamydia pneumoniae immunoglobulin A reactivation and airway inflammation in acute asthma. Eur Respir J 20(4):834–840PubMedCrossRef

56.

Sutherland ER, Martin RJ (2007) Asthma and atypical bacterial infection. Chest 132(6):1962–1966PubMedCrossRef

57.

Nagel G et al (2012) Association of pertussis and measles infections and immunizations with asthma and allergic sensitization in ISAAC Phase Two. Pediatr Allergy Immunol 23(8):737–746PubMedCrossRef

58.

Burgess JA et al (2012) Childhood infections and the risk of asthma: a longitudinal study over 37 years. Chest 142(3):647–654PubMedCrossRef

59.

Denning DW et al (2006) The link between fungi and severe asthma: a summary of the evidence. Eur Respir J 27(3):615–626PubMedCrossRef

60.

Targonski PV, Persky VW, Ramekrishnan V (1995) Effect of environmental molds on risk of death from asthma during the pollen season. J Allergy Clin Immunol 95(5 Pt 1):955–961PubMedCrossRef

61.

Jaakkola MS, Ieromnimon A, Jaakkola JJ (2006) Are atopy and specific IgE to mites and molds important for adult asthma? J Allergy Clin Immunol 117(3):642–648PubMedCrossRef

62.

Knutsen AP et al (2012) Fungi and allergic lower respiratory tract diseases. J Allergy Clin Immunol 129(2):280–291, quiz 292–3PubMedCrossRef

63.

Denning DW et al (2009) Randomized controlled trial of oral antifungal treatment for severe asthma with fungal sensitization: The Fungal Asthma Sensitization Trial (FAST) study. Am J Respir Crit Care Med 179(1):11–18PubMedCrossRef

64.

Crim C et al (2009) Pneumonia risk in COPD patients receiving inhaled corticosteroids alone or in combination: TORCH study results. Eur Respir J 34(3):641–647PubMedCrossRef

65.

Rodrigo GJ, Castro-Rodriguez JA, Plaza V (2009) Safety and efficacy of combined long-acting beta-agonists and inhaled corticosteroids vs long-acting beta-agonists monotherapy for stable COPD: a systematic review. Chest 136(4):1029–1038PubMedCrossRef

66.

McKeever T et al (2013) Inhaled corticosteroids and the risk of pneumonia in people with asthma: a case control study. Chest 144:1788–1794PubMedCrossRef

67.

Graham VA et al (1982) Routine antibiotics in hospital management of acute asthma. Lancet 1(8269):418–420PubMedCrossRef

68.

Shapiro GG et al (1974) Double-blind study of the effectiveness of a broad spectrum antibiotic in status asthmaticus. Pediatrics 53(6):867–872PubMed

69.

Koutsoubari I et al (2012) Effect of clarithromycin on acute asthma exacerbations in children: an open randomized study. Pediatr Allergy Immunol 23(4):385–390PubMedCrossRef

70.

Johnston SL et al (2006) The effect of telithromycin in acute exacerbations of asthma. N Engl J Med 354(15):1589–1600PubMedCrossRef

71.

Richeldi L et al (2005) Macrolides for chronic asthma. Cochrane Database Syst Rev 4:CD002997PubMed

72.

Brusselle GG et al (2013) Azithromycin for prevention of exacerbations in severe asthma (AZISAST): a multicentre randomised double-blind placebo-controlled trial. Thorax 68(4):322–329PubMedCrossRef

Titel: Infection in Severe Asthma Exacerbations and Critical Asthma Syndrome
verfasst von: Christian E. Sandrock
Andrew Norris
Publikationsdatum: 01.02.2015
Verlag: Springer US
Erschienen in: Clinical Reviews in Allergy & Immunology / Ausgabe 1/2015
Print ISSN: 1080-0549
Elektronische ISSN: 1559-0267
DOI: https://doi.org/10.1007/s12016-014-8435-x

Update HNO

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.

Newsletter bestellen

Springer Medizin

Infection in Severe Asthma Exacerbations and Critical Asthma Syndrome

Abstract

Neu im Fachgebiet HNO

Akuter Schwindel: Wann lohnt sich eine MRT?

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

HNO-Op. auch mit über 90?

Intrakapsuläre Tonsillektomie gewinnt an Boden

Update HNO

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2015

Immunobiology of the Critical Asthma Syndrome

The Acute Management of Asthma

Pulmonary Vasculature and Critical Asthma Syndromes: a Comprehensive Review

Pharmacotherapy of Critical Asthma Syndrome: Current and Emerging Therapies

Definition of Critical Asthma Syndromes

Management of Critical Asthma Syndrome During Pregnancy

Neu im Fachgebiet HNO

Akuter Schwindel: Wann lohnt sich eine MRT?

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

HNO-Op. auch mit über 90?

Intrakapsuläre Tonsillektomie gewinnt an Boden

Update HNO